Pathogenesis of Autoimmune Disease Flashcards

1
Q

What happens in rheumatoid arthiritis?

A
  • Chronic joint inflammation that can result in joint damage
  • If untreated -> pain, discomfort and destruction of the joint
  • Site of inflammation is the synovium (lining of synovial joints) - chronic sinovitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which antibodies are associated with rheumatoid arthritis?

A

Rheumatoid factor

Anti-cyclic citrullinated peptide (CCP) antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an enthesis?

A

where the tendon inserts into the bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens in ankylosing spondylitis?

A
  • Chronic spinal inflammation that can result in spinal fusion and deformity
  • Untreated -> pain and inflammation of the spine, bony fusion of the vertebrae
  • Patients have an exaggerated thoracic kyphosis
  • Site of inflammation is the enthesis (joints vertebrae together)
  • ENTHESITIS -> calcium deposition and BONY FUSION
  • No autoantibodies (‘seronegative’)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are examples of seronegative spondyloarthropathies?

A
  • Ankylosing spondylitis
  • Reiters syndrome and reactive arthritis
  • Arthritis associated with psoriasis (psoriatic arthritis)
  • Arthritis associated with gastrointestinal inflammation (enteropathic synovitis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens in systemic lupus erythematosus?

A
  • Chronic tissue inflammation in the presence of antibodies directed against self antigens
  • PATHOGENESIS IS DRIVEN BY AUTOANTIBODIES AND IMMUNE COMPLEXES (antibody + antigen)
  • antibodies are referred to anti-nuclear antibodies
  • Multi-site inflammation but particularly the joints, skin and kidney
  • Immune complexes trigger inflammation by activating complement and binding to Fc receptors for antibody (can be inflammatory and anti-inflammatory). Because immune complexes can circulate all over the body and deposit in various places, the problems that occur in SLE are very widespread
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are examples of connective tissue diseases?

A
  • Systemic lupus erythematosus
  • Inflammatory muscle disease: polymyositis, dermatomyositis
  • Systemic sclerosis
  • Sjogren’s syndrome
  • A mixture of the above: ‘Overlap syndromes’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a HLA?

A

human leukocyte antigen

encoded in a gene locus called the major histocompatibility complex

They encode surface proteins. There are various serotypes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the types of HLA moleucules?

A

MHC class I : HLA - A,B.C

MHC class II : HLAA - DR molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which class of MHC are SLE, rheumatoid arthritis and ankylosing spondylitis associated with?

A

SLE and rheumatoid arthritis - MCH Class II

ankylosing spondylitis - MCH Class II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of MCH Class I and II molecules?

A

present antigens to T cells

  • Class I HLA molecules are present on ALL nucleated cells, and bind endogenous antigens - they are recognised by CD8+ T-cells
  • Class II HLA molecules are present on APCs (dendritic cells, B cells, macrophages etc.) - generally present exogenous molecules, and recognised by CD4 T-cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What antibodies are associated with SLE?

A
  • Antinuclear antibodies

- Anti-double stranded DNA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do antinuclear antibodies react to?

A

antigen deep in the cell, within the nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What’s the next step if ANA is positive in the lab?

A

perform further tests to determine which type of ANA it is
- Typically these include screening for: Anti-Ro, Anti-La, Anti-centromere, Anti-Sm, Anti-RNP, Anti-ds-DNA antibodies and Anti-Scl-70

Cytoplasmic antibodies include:

  • Anti-tRNA synthetase antibodies
  • Anti-ribosomal P antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does a sick lupus patient commonly have?

A
  • Low complement levels

- High serum levels of anti-ds-DNA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are nuclear antigens accessible to the immune response?

A

Apoptosis results in the translocation of certain nuclear antigens to the surface of the apoptotic cell

17
Q

Describe the pathogenesis of lupus

A

In lupus, apoptotic cells are not cleared normally so this impaired clearance enables abnormal presentation to the immune system.

The immune response is amplified through the B cells.

The autoantibodies are normally detectable in patients about 10 year before the symptoms start to appear.

18
Q

What are the types of CD4+ cells? What do they secrete?

A

T helper cell subsets include: Th1, Th2 and Th17

Th1 cells secrete IL-2 and γ-IFN and response is important in CD8+ cytotoxicity and macrophage stimulation

Th2 cells secrete IL-4 (IgE responses), IL-5 (eosinophils), IL-6 (B cells to plasma cells) and IL-10 (inhibit macrophage response)

Th17 cells develop in response to IL-23 and secrete IL-17, a potent cytokine, which triggers IL-6, IL-8, TNFα, matrix metalloproteinases and RANKL in target cells

19
Q

What is biological therapy?

A

cytokines from t helper cells can be manipulated and switched off by monoclonal antibodies

20
Q

Whats the dominant pro-inflammatory cytokine in rheumatoid arthritis?

A

TNF alpha (from activated macrophages)

21
Q

What does TNF-a do?

A
  • Activate osteoclasts -> bone erosion
  • Activate synoviocytes -> joint inflammation and swelling (due to increased production of synovial fluid)
  • Activate chondrocytes -> cartilage degradation
  • PGE2 production
  • angiogenesis
  • leukocyte accumulation
  • endothelial cell activation
  • chemokine release
22
Q

What is rituximab?

A

antibody against a B cell surface antigen, CD20

In addition to cytokine blockade, we can also deplete B cells in rheumatoid arthritis by parenteral (intravenous) - rituximab

23
Q

What is RANKL?

A

receptor activator of nuclear factor kB ligand

Produced by T cells and synovial fibroblasts in rheumatoid arthritis

  • Acts to stimulate osteoclast formation (osteoclastogenesis) - binds to osteoclast precursor
  • Up-regulated by: Interleukin-1, TNF-a, Interleukin-17 and PTH-related peptide
  • Interleukin-17 is a potent action on osteoclastogenesis via RANKL-RANK pathway
24
Q

What antagonises RANKL?

A

decoy receptor – osteoprotegerin (OPG)

25
Q

What is denosumab?

A

a monoclonal antibody against RANKL (isn’t used in rheumatoid arthritis)

-indicated for osteoporosis, bone metastases, multiple myeloma and giant cell tumours treatment

26
Q

What therapies are used to treat SLE?

A

Rituximab – a chimeric anti-CD20 antibody used to deplete B cells
- anecdotal therapeutic success rituximab, clinical trials unsuccessful to date

Belimumab – a monoclonal antibody against a B cell survival factor call BLYS

  • BELIMUMAB is a recombinant fully human IgG1 monoclonal antibody against BLYS (also termed BAFF)
  • inhibits activity of BAFF resulting in impaired B cell survival and reduced B cell numbers
  • BAFF = B cell activating factor of the tumour necrosis factor family
  • BLYS = B-lymphocyte stimulator
27
Q

What are prostaglandins?

A

lipid mediators of inflammation that act on platelets, endothelium, uterine tissue and mast cells.

They are synthesized from essential fatty acids: phospholipase A2 generates arachidonic acid from diacylglycerol in cell membranes.

28
Q

What are the two pathways for arachadonic acid?

A

Cyclooxygenase pathway: arachidonic acid prostaglandins
- Prostaglandins mediate e.g. vasodilatation (PGI2/prostacyclin, via receptor called IP), inhibit platelet aggregation (PGI2), bronchodilation (e.g. PGE2 acting via receptor called EP2, PGI2), uterine contraction (PGF2alpha).

Lipooxygenase pathway: arachidonic acid -> leukotrienes
- Leukotrienes mediate leucocyte chemotaxis (LTB4) and smooth muscle contraction, bronchoconstriction and mucus secretion (LTC4, LTD4, LTE4 via CysLT1 receptors)

29
Q

What are the pros and cons of NSAIDS?

A

Benefits: analgesia, anti-pyretic, anti-inflammatory and anti-platelet (thromboxane A2)
- generally used to deal with pain

Unwanted effects: e.g. asthma exacerbation, gastro-intestinal ulcers, thrombosis, liver and renal problems

  • They are NOT effective at preventing joint damage long term